|Issuer:||RXSIGHT, INC. (RXST)|
|Original Submission Date:|
C/O RXSIGHT, INC.
100 COLUMBIA ALISO VIEJO, CA 92656
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|STOCK OPTION (RIGHT TO BUY)||14.95||2023-03-09||deemed execution date||A||95,000 (a)||2033-03-09||common stock 95,000||$14.95||95,000||direct|
|f1||subject to the reporting person continuing to be a service provider (as defined in the issuer's 2021 equity incentive plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the vesting commencement date on the same day of the month as the vesting commencement date (and if there is no corresponding day, on the last day of the month). "vesting commencement date" shall mean march 9, 2023.|